FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to a process for the preparation of thieno[3,2-d]pyrimidine compound of formula (I), or a pharmaceutically acceptable salt thereof, which comprises the steps of 1–3:
.
Invention also relates to a process for the preparation of a compound of formula
.
Radical values are given in claim 1.
EFFECT: method of preparing a pharmaceutically acceptable salt is provided.
17 cl, 125 ex, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| TIENOPYRIMYDINE [3,2-D] PRODUCTION, WHICH HAS INHIBITORY ACTIVITY AGAINST PROTEIN KINASES | 2012 |
|
RU2625799C2 |
| THIENO[3,2-d]PYRIMIDINE DERIVATIVES, POSSESSING INHIBITING ACTION WITH RESPECT TO PROTEINKINASE | 2011 |
|
RU2524210C2 |
| NEW AMINOARYL DERIVATIVE SUITABLE AS A DIACYLGLYCEROLACYL TRANSFERASE 2 INHIBITOR AND ITS APPLICATION | 2020 |
|
RU2799819C1 |
| NOVEL FUSED PYRIMIDINE DERIVATIVES FOR INHIBITION OF TYROSINE KINASE ACTIVITY | 2011 |
|
RU2585177C2 |
| BICYCLIC DIHYDROPYRIMIDINECARBOXAMIDE DERIVATIVES AS RHO-KINASE INHIBITORS | 2017 |
|
RU2778478C2 |
| NEW AMIDE DERIVATIVE USED AS AN INHIBITOR OF DIALGLYCEROL O-ACYLTRANSFERASE 2 AND ITS USE | 2020 |
|
RU2810064C1 |
| NEW INDOLIZINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2013 |
|
RU2646223C2 |
| NEW BIARYL DERIVATIVE USED AS INHIBITOR OF DIACYLGLYCEROL ACYLTRANSFERASE 2 AND ITS USE | 2021 |
|
RU2808433C1 |
| NEW PHENYLPYRIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVE | 2018 |
|
RU2748945C1 |
| INHIBITOR COMPOUNDS | 2013 |
|
RU2673079C2 |
